FDA Inspection 1008520 — MedStar Georgetown Medical Center Inc Georgetown University Hospital

MedStar Georgetown Medical Center Inc Georgetown University Hospital — FEI 1174826

The FDA completed an inspection of MedStar Georgetown Medical Center Inc Georgetown University Hospital on March 24, 2017 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 24, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Washington, DC (United States)